abstract |
PV PERUEH\Res CIms\2008\Au8\3063I 42 di, spei pagsdc-15/O82008 Abstract New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise in particular administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkins lymphomas. |